To show your support of this position statement, please send an e-mail with your intent, and affiliation to danielle.bonadies@yale.edu<\/a> <\/p>\n Below please find the full text on a Genetic Testing Lab Position Statement that pledges we, the ordering clinicians, will continue to make laboratory and testing choices based on what is in the best interest of our patients and will not be swayed by political, personal or financial gain. <\/p>\n This is also an opportune time for patient organizations, clinical organizations and insurers to show their support of laboratories that will fully share past, current and future data in open databases that serve research and patient care. <\/p>\n Please pass this on to your family, friends, colleagues, patients and contacts within your networks. <\/p>\n Genetic Testing Position Statement <\/p>\n Cancer Genetic Counseling Program Yale School of Medicine\/Yale Cancer Center <\/p>\n New Haven, CT February 2014 <\/p>\n With the emergence of new testing technologies and the 2013 Supreme Court decision banning gene patenting, the available cancer genetic testing options and the laboratories offering testing have expanded exponentially and are likely to continue to do so. As providers we have a responsibility to our patients to make the best decisions regarding which laboratory to use and which tests are most appropriate based on what is best for the patients. Our decisions will not be swayed by political, personal and\/or financial gain. <\/p>\n 2. Time: How long will the patient have to wait for his or her test results? <\/p>\n 3. Cost: Will our patients insurance carrier cover this test at this laboratory? <\/p>\n <\/p>\n See the article here:<\/p>\n Cancer Genetic Counseling<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" To show your support of this position statement, please send an e-mail with your intent, and affiliation to danielle.bonadies@yale.edu<\/a> Below please find the full text on a Genetic Testing Lab Position Statement that pledges we, the ordering clinicians, will continue to make laboratory and testing choices based on what is in the best interest of our patients and will not be swayed by political, personal or financial gain. This is also an opportune time for patient organizations, clinical organizations and insurers to show their support of laboratories that will fully share past, current and future data in open databases that serve research and patient care Continue reading